PHASE II TRIAL OF CONTINUOUS SUNITINIB IN PATIENTS WITH RECURRENT OR PROGRESSIVE GLIOBLASTOMA (SURGE 01-07)

被引：0
|
作者：
Hutterer, Markus [1 ]
Martha, Nowosielski [2 ]
Sabine, Embacher [2 ]
Thaddaeus, Gotwald [2 ]
Florian, Stockhammer [3 ]
Christine, Marosi [4 ]
Stefan, Oberndorfer [5 ]
Richard, Greil [1 ]
Martin, Moik [1 ]
Johanna, Buchroithner [6 ]
Jochen, Tuettenberg [7 ]
Ullrich, Herrlinger [8 ]
Wolfgang, Wick [9 ]
Peter, Vajkoczy [3 ]
Guenther, Stockhammer [2 ]
机构：
[1] Paracelsus Med Univ Salzburg, Salzburg, Austria
[2] Med Univ Innsbruck, Innsbruck, Austria
[3] Charite, Berlin, Germany
[4] Med Univ Vienna, Vienna, Austria
[5] Kaiser Franz Josef Hosp Vienna, Vienna, Austria
[6] Wagner Jauregg Hosp Linz, Linz, Austria
[7] Med Univ Heidelberg, Univ Hosp Mannheim, Mannheim, Germany
[8] Univ Hosp Bonn, Bonn, Germany
[9] Univ Heidelberg Hosp, Heidelberg, Germany
来源：
NEURO-ONCOLOGY | 2011年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [1] A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07)
    Hutterer, Markus
    Nowosielski, Martha
    Haybaeck, Johannes
    Embacher, Sabine
    Stockhammer, Florian
    Gotwald, Thaddaeus
    Holzner, Bernhard
    Capper, David
    Preusser, Matthias
    Marosi, Christine
    Oberndorfer, Stefan
    Moik, Martin
    Buchroithner, Johanna
    Seiz, Marcel
    Tuettenberg, Jochen
    Herrlinger, Ulrich
    Wick, Antje
    Vajkoczy, Peter
    Stockhammer, Guenther
    [J]. NEURO-ONCOLOGY, 2014, 16 (01) : 92 - 102
  • [2] A PHASE II TRIAL OF SUNITINIB IN THE TREATMENT OF RECURRENT GLIOBLASTOMA (GBM)
    Kreisl, Teri N.
    Smith, P.
    Iwamoto, Fabio
    Sul, Joohee
    Butman, John A.
    Fine, Howard A.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 71 - 72
  • [3] Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
    Kaley, Thomas J.
    Wen, Patrick
    Schiff, David
    Ligon, Keith
    Haider, Sam
    Karimi, Sasan
    Lassman, Andrew B.
    Nolan, Craig P.
    DeAngelis, Lisa M.
    Gavrilovic, Igor
    Norden, Andrew
    Drappatz, Jan
    Lee, Eudocia Quant
    Purow, Benjamin
    Plotkin, Scott R.
    Batchelor, Tracy
    Abrey, Lauren E.
    Omura, Antonio
    [J]. NEURO-ONCOLOGY, 2015, 17 (01) : 116 - 121
  • [4] A PHASE II AND PHARMACODYNAMIC TRIAL OF RO4929097 FOR PATIENTS WITH RECURRENT/PROGRESSIVE GLIOBLASTOMA
    Peereboom, David M.
    Mikkelson, Tom
    Sloan, Andrew E.
    Rich, Jeremy N.
    Supko, Jeffrey G.
    Ye, Xiaobu
    Brewer, Cathy
    Lamborn, Kathleen
    Prados, Michael
    Grossman, Stuart A.
    [J]. NEURO-ONCOLOGY, 2011, 13 : 86 - 86
  • [5] A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma
    Peereboom, David M.
    Ye, Xiaobu
    Mikkelsen, Tom
    Lesser, Glenn J.
    Lieberman, Frank S.
    Robins, H. Ian
    Ahluwalia, Manmeet S.
    Sloan, Andrew E.
    Grossman, Stuart A.
    [J]. NEUROSURGERY, 2021, 89 : S80 - S80
  • [6] A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma
    Peereboom, David M.
    Ye, Xiaobu
    Mikkelsen, Tom
    Lesser, Glenn J.
    Lieberman, Frank S.
    Robins, H. Ian
    Ahluwalia, Manmeet S.
    Sloan, Andrew E.
    Grossman, Stuart A.
    [J]. NEUROSURGERY, 2021, 88 (02) : 246 - 251
  • [7] The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma
    Janssen, Jorien B. E.
    Brahm, Cyrillo G.
    Driessen, Chantal M. L.
    Nuver, Janine
    Labots, Mariette
    Kouwenhoven, Mathilde C. M.
    Aliaga, Esther Sanchez
    Enting, Roelien H.
    de Groot, Jan Cees
    Walenkamp, Annemiek M. E.
    van Linde, Myra E.
    Verheul, Henk M. W.
    [J]. BRAIN COMMUNICATIONS, 2024, 6 (04)
  • [8] A phase II and pharmacodynamic trial of RO4929097 for patients with recurrent/progressive glioblastoma.
    Peereboom, D. M.
    Rich, J. N.
    Supko, J. G.
    Lamborn, K.
    Ye, X.
    Sloan, A. E.
    Prados, M.
    Grossman, S. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma COMMENT
    Thakkar, Jigisha P.
    Barton, Kevin P.
    Prabhu, Vikram C.
    [J]. NEUROSURGERY, 2021, 88 (02) : 251 - 251
  • [10] A Phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study
    Brahm, Cyrillo G.
    van Linde, Myra E.
    Labots, Mariette
    Kouwenhoven, Mathilde C.
    Aliaga, Esther Sanchez
    Enting, Roelien H.
    Appelman, Auke P.
    Nuver, Janine
    Walenkamp, Annemiek M.
    Verheul, Henk M.
    [J]. CANCER RESEARCH, 2019, 79 (13)
12345